A significant breakthrough in cancer research is arising with the use of nanobodies to reactivate dysfunctional p53. This essential cancer inhibitor protein is frequently disabled in many types of malignancies, https://bookmarkfly.com/story21942271/mini-antibodies-revive-p53-the-potential-hope-for-tumor-management